Skip to content

The influence of fast-track surgery on the bone condition around prothesis after total hip arthroplasty

fast-track surgery to periprosthetic bone remodeling after total hip replacement: a single-center, prospective double-blinded randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010451
Enrollment
Unknown
Registered
2017-01-16
Start date
2017-02-02
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total hip arthroplasty

Interventions

fast-track group:fast-track perioperative treatment
no fast-track surgery group:standard perioperative treatment

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Osteonecrois of the femoral head accord with ARCO staging IIIc~IV; 2. Male or female, aged 18 to 75 years old; 3. Willing to undergo total hip arthroplasty to treat osteonecrois of the femoral head; 4. Agreement on abandoning other treatment; 5. All patiens should sign on informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with uncontrollable cardiovascular disease, diabetes, liver and kidney dysfunction and alleosis preoperative; 2. Severe smoking and drinking history, lacking essential economic and social support; 3. Any preserving hip treatment preoperatively that effect the total hip arthroplasty; 4. Other disease resulting in hip pain; 5. ASA level greater than III; 6. Undesirable bone condition measured by X-ray preoperative; 7. Hypersensitive reaction to medicine used in treatment process.

Design outcomes

Primary

MeasureTime frame
degree of stress shielding;incidence of stress shielding;

Secondary

MeasureTime frame
average postoperative walking distance;average exercise frequency;

Countries

China

Contacts

Public ContactJianguo Liu

The First Hospital of Jilin University

liu_jg@jlu.edu.cn+86 13756661600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026